LEADER 04164nam 2201177z- 450 001 9910580204803321 005 20231214133255.0 035 $a(CKB)5690000000012042 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87408 035 $a(EXLCZ)995690000000012042 100 $a20202207d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRecent Advances in Antibody Therapeutics 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (238 p.) 311 $a3-0365-4353-8 311 $a3-0365-4354-6 330 $aSince first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, ?Recent Advances in Antibody Therapeutics?, presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies 606 $aResearch & information: general$2bicssc 606 $aChemistry$2bicssc 610 $ainterleukin 33 610 $aST2 receptor 610 $ascFv 610 $aC2_2E12 610 $abladder cancer 610 $aantibodies 610 $aimmune checkpoint inhibitors 610 $aantibody-drug conjugates 610 $asacituzumab govitecan 610 $aenfortumab vedotin 610 $aerdafitinib 610 $acost-effectiveness 610 $aG protein-coupled receptor 610 $amembrane protein 610 $aantigen 610 $atherapeutic antibody 610 $aanti-angiogenesis 610 $adelta-like ligand 610 $airinotecan 610 $apaclitaxel 610 $aVEGF 610 $aSARS-CoV-2 610 $aspike protein 610 $areceptor-binding domain 610 $aphage display 610 $amonoclonal antibody 610 $acytomegalovirus 610 $apeptide/major histocompatibility complex class I complex 610 $aT-cell-receptor-like antibody 610 $aaffinity maturation 610 $ayeast surface display 610 $acombinatorial antibody library 610 $aagonist antibody 610 $acell fate 610 $abispecific antibodies 610 $abioassays 610 $amechanisms of action 610 $abinding assays 610 $apotency assays 610 $aatherosclerosis 610 $ainflammation 610 $aantibody therapy 610 $ablood-brain barrier 610 $aantibody 610 $apharmacokinetics 610 $adisposition 610 $abiochemical and physicochemical properties 610 $aFc binding 610 $areceptor-mediated transcytosis 610 $abrain shuttle 610 $amolecular Trojan horse 610 $atransferrin 610 $aanti-cancer antibody 610 $aantibody engineering 610 $abiophysical properties 610 $acomputational methods 610 $aresearch cell bank 610 $aantibody therapeutics 610 $arecombinant antibodies 610 $aintracellular antibodies 610 $asingle-chain antibody fragment 610 $ananobody 610 $aHuman papillomaviruses 610 $aHPV oncoproteins 610 $aHPV-associated cancer 610 $aHPV cancer therapy 610 $aasthma 610 $arefractory asthma 610 $abiomarker 615 7$aResearch & information: general 615 7$aChemistry 700 $aHeo$b Yong-Seok$4edt$01332302 702 $aHeo$b Yong-Seok$4oth 906 $aBOOK 912 $a9910580204803321 996 $aRecent Advances in Antibody Therapeutics$93040802 997 $aUNINA